Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

École Polytechnique de Montréal

$48,000.00

METALLIC NANOPARTICLE-MEDIATED ULTRAFAST LASER NANOPROCESSES FOR NANOMEDICINE APPLICATIONS

EF 2024-25

Résumé
Nanomedicine, the branch of nanotechnology dealing with bringing applications to the medical world, seeks to deliver strategies to address important illnesses such as cancer. It is anticipated that nanomedicine will also provide the means to overcome biological barriers, precisely deliver drugs, and selectively target sites within the body affected by a disease. The proposed research program specifically deals with the fundamentals and applications of ultrafast (UF) lasers in the context of nanomedicine, mostly emphasizing the engineering developments and multiphysics modeling of UF laser irradiation regimes and the optimization of interactions with novel metallic nanoparticle (NPs) platforms. Two interrelated approaches will be developed. The first approach will involve laser-induced nanoprocesses enhanced by metallic NPs. The project will explore optimizing the interaction between an UF laser pulse with plasmonic NPs to induce the novel effect of off-resonance plasma-mediated nanocavitation. Such processes are anticipated to enable selective and scalable cell transfection, drug delivery for cancer, and gene therapy for eye illnesses. This approach will deal with nanoprocesses based on hot-electron generation and nanoplasma under cumulative UF laser excitation of metallic NPs. In this regime, photochemical processes will be explored under longer exposures to lower-intensity UF laser irradiation, as in photodynamic therapy. We will directly compare photodynamic therapy efficiencies between gold nanoclusters and plasmonic NPs with an UF laser, which remains unexplored. The role of accompanied photothermal effects will be further considered. The second approach will deal with UF laser light-triggered release of drugs/genes from novel liposome-gold nanoparticle hybrids with the aim of inducing local delivery, thus presenting an important advantage of limiting side effects to patients. Toward the development of the laser-triggered release technology, we aim to incorporate gold nanorods in engineered liposomes containing drugs or genes to enhance the penetration depth and localization of the triggered interaction. Over the 5 years, the Discovery research program will contribute to the training of 5 undergraduate students, 3 masters, 2 PhDs, two postdoctoral fellows, and a technician. This highly qualified personnel will be trained in nanotechnologies, laser technologies, and multiphysics modeling for various applications in nanomedicine, which are highly relevant to many Canadian biomedical industries, research centres, universities, and hospitals. In summary, this research is expected to bring new basic knowledge, materials, and technologies for UF laser-metallic nanoparticle-induced nanoprocesses. In the long term, the findings and technologies developed from this research will contribute, in collaboration with medical experts, to the development of multifunctional therapeutic tools used in the fight against diseases in oncology and ophthalmology.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2024-06832
Name nom
Meunier, Michel
Department département
Génie physique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
48000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3111
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Lasers
Research subject fr
Laser
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
METALLIC NANOPARTICLE-MEDIATED ULTRAFAST LASER NANOPROCESSES FOR NANOMEDICINE APPLICATIONS
Keywords
plasmonics; ultrafast laser; nanotechnology; nanosurgery; plasmonic nanostructures; biophysics; drug delivery; physical simulations; multiphysics modeling; metallic nanocrystals
Application summary
Nanomedicine, the branch of nanotechnology dealing with bringing applications to the medical world, seeks to deliver strategies to address important illnesses such as cancer. It is anticipated that nanomedicine will also provide the means to overcome biological barriers, precisely deliver drugs, and selectively target sites within the body affected by a disease. The proposed research program specifically deals with the fundamentals and applications of ultrafast (UF) lasers in the context of nanomedicine, mostly emphasizing the engineering developments and multiphysics modeling of UF laser irradiation regimes and the optimization of interactions with novel metallic nanoparticle (NPs) platforms. Two interrelated approaches will be developed. The first approach will involve laser-induced nanoprocesses enhanced by metallic NPs. The project will explore optimizing the interaction between an UF laser pulse with plasmonic NPs to induce the novel effect of off-resonance plasma-mediated nanocavitation. Such processes are anticipated to enable selective and scalable cell transfection, drug delivery for cancer, and gene therapy for eye illnesses. This approach will deal with nanoprocesses based on hot-electron generation and nanoplasma under cumulative UF laser excitation of metallic NPs. In this regime, photochemical processes will be explored under longer exposures to lower-intensity UF laser irradiation, as in photodynamic therapy. We will directly compare photodynamic therapy efficiencies between gold nanoclusters and plasmonic NPs with an UF laser, which remains unexplored. The role of accompanied photothermal effects will be further considered. The second approach will deal with UF laser light-triggered release of drugs/genes from novel liposome-gold nanoparticle hybrids with the aim of inducing local delivery, thus presenting an important advantage of limiting side effects to patients. Toward the development of the laser-triggered release technology, we aim to incorporate gold nanorods in engineered liposomes containing drugs or genes to enhance the penetration depth and localization of the triggered interaction. Over the 5 years, the Discovery research program will contribute to the training of 5 undergraduate students, 3 masters, 2 PhDs, two postdoctoral fellows, and a technician. This highly qualified personnel will be trained in nanotechnologies, laser technologies, and multiphysics modeling for various applications in nanomedicine, which are highly relevant to many Canadian biomedical industries, research centres, universities, and hospitals. In summary, this research is expected to bring new basic knowledge, materials, and technologies for UF laser-metallic nanoparticle-induced nanoprocesses. In the long term, the findings and technologies developed from this research will contribute, in collaboration with medical experts, to the development of multifunctional therapeutic tools used in the fight against diseases in oncology and ophthalmology.